PSEN2 and glioblastoma: Xue Shen and colleagues transfected the recombinant adenovirus 5-EVA1A vector (ad5-EVA1A) into glioblastoma (GBM) cells to overexpress EVA1A in order to analyse its antitumor activity in vitro.